HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Aldo Tomasi Selected Research

Secondary Headache Disorders

1/2015Validation of potential candidate biomarkers of drug-induced nephrotoxicity and allodynia in medication-overuse headache.
1/2013Discovery by a proteomic approach of possible early biomarkers of drug-induced nephrotoxicity in medication-overuse headache.
1/2012Proteomic analysis of urine in medication-overuse headache patients: possible relation with renal damages.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Aldo Tomasi Research Topics

Disease

13Neoplasms (Cancer)
04/2021 - 01/2013
9Melanoma (Melanoma, Malignant)
01/2020 - 10/2012
8Prostatic Neoplasms (Prostate Cancer)
01/2021 - 01/2014
7Headache (Headaches)
11/2021 - 01/2012
5Inflammation (Inflammations)
11/2021 - 01/2014
5Migraine Disorders (Migraine)
11/2021 - 05/2020
4Pain (Aches)
11/2021 - 12/2015
4COVID-19
07/2021 - 01/2020
4Atherosclerosis
06/2020 - 11/2009
3Periodontal Pocket (Periodontal Pockets)
05/2021 - 06/2013
3Secondary Headache Disorders
01/2015 - 01/2012
2Migraine without Aura (Common Migraine)
11/2021 - 10/2020
2Restless Legs Syndrome (Restless Legs)
10/2019 - 10/2018
2Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
09/2018 - 01/2014
2Chronic Pain
01/2017 - 12/2015
2Gastrointestinal Neoplasms (Gastrointestinal Cancer)
05/2016 - 06/2014
2Prescription Drug Overuse
01/2015 - 01/2013
2Neurofibromatosis 1 (Neurofibromatosis Type I)
06/2014 - 10/2012
2Basal Cell Nevus Syndrome (Gorlin Syndrome)
01/2013 - 08/2012
2Acne Vulgaris
06/2006 - 01/2004
2Ischemia
12/2005 - 11/2005
2Myocardial Ischemia (Ischemic Heart Diseases)
11/2005 - 09/2003
1Infections
07/2021
1Hemorrhage
05/2021
1Cognitive Dysfunction
03/2021
1Epilepsy (Aura)
10/2020
1Dyslipidemias (Dyslipidemia)
06/2020
1Neuroinflammatory Diseases
05/2020
1Disseminated Intravascular Coagulation
01/2020
1Neoplasm Metastasis (Metastasis)
01/2020
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2020
1Disease Progression
01/2020
1Systemic Vasculitis
01/2020
1Sleepiness
10/2019
1Thyroid Neoplasms (Thyroid Cancer)
09/2019
1Pleural Effusion (Pleural Effusions)
09/2019
1Neuralgia (Stump Neuralgia)
01/2017
1Microsatellite Instability
11/2016
1Hereditary Neoplastic Syndromes (Cancer Syndrome, Hereditary)
05/2016
1Intestinal Polyps
05/2016
1Basal Cell Carcinoma (Rodent Ulcer)
05/2016

Drug/Important Bio-Agent (IBA)

19Biomarkers (Surrogate Marker)IBA
07/2021 - 04/2008
17Proteins (Proteins, Gene)FDA Link
04/2021 - 03/2010
6Cell-Free Nucleic AcidsIBA
01/2021 - 04/2018
6Blood Proteins (Serum Proteins)IBA
10/2018 - 11/2009
5Peptides (Polypeptides)IBA
09/2010 - 09/2003
4DNA (Deoxyribonucleic Acid)IBA
01/2021 - 04/2018
4Biological ProductsIBA
01/2021 - 03/2013
4Free RadicalsIBA
06/2006 - 09/2003
3Pregnanolone (Allopregnanolone)IBA
11/2021 - 10/2020
3HomocysteineIBA
07/2021 - 10/2020
3ProteomeIBA
04/2021 - 06/2013
3Hormones (Hormone)IBA
03/2021 - 09/2003
3Tryptamines (Triptans)IBA
01/2015 - 01/2012
3Analgesics (Analgesic Drugs)IBA
01/2015 - 01/2012
3Pharmaceutical PreparationsIBA
01/2015 - 01/2004
3Apolipoproteins E (ApoE)IBA
09/2010 - 11/2009
2pregnenolone sulfateIBA
11/2021 - 03/2021
2NeurosteroidsIBA
11/2021 - 03/2021
2CytokinesIBA
06/2020 - 01/2020
2ApolipoproteinsIBA
09/2010 - 03/2010
2Benzoyl PeroxideFDA LinkGeneric
06/2006 - 01/2004
2AntioxidantsIBA
06/2006 - 04/2003
2MelanocortinsIBA
11/2005 - 09/2003
2Adrenocorticotropic Hormone (ACTH)FDA Link
11/2005 - 09/2003
1Dehydroepiandrosterone SulfateIBA
11/2021
1Dehydroepiandrosterone (DHEA)IBA
11/2021
1PregnenoloneIBA
11/2021
1Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
07/2021
1N- (2- amino- 3- (4- isothiocyanatophenyl)propyl)cyclohexane- 1,2- diamine- N,N',N',N'',N''- pentaacetic acidIBA
05/2021
1ChlorhexidineIBA
05/2021
12-(4-fluorophenyl)-N-methylsuccinimideIBA
05/2021
1Tuberculin (PPD)IBA
05/2021
1Capsules (Microcapsules)IBA
04/2021
1Estradiol (Delestrogen)FDA LinkGeneric
03/2021
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
03/2021
1Testosterone (Sustanon)FDA Link
10/2020
1ProgesteroneFDA LinkGeneric
10/2020
1LipidsIBA
06/2020
1Apolipoprotein B-100 (Apo B 100)IBA
06/2020
1oxidized low density lipoproteinIBA
06/2020
1LDL Lipoproteins (beta Lipoproteins)IBA
06/2020
1Complement System Proteins (Complement)IBA
06/2020
1Lipoproteins (Lipoprotein)IBA
06/2020
1C-Reactive ProteinIBA
01/2020
1fibrin fragment D (D-dimer)IBA
01/2020
1ProcalcitoninIBA
01/2020
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2020
1Creatine Kinase (Creatine Phosphokinase)IBA
01/2020
1Dacarbazine (DIC)FDA LinkGeneric
01/2020
1InterleukinsIBA
01/2020
1ParaffinIBA
01/2020
1TroponinIBA
01/2020
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
12/2017
1Sulfhydryl Compounds (Thiols)IBA
11/2016
1Polytetrafluoroethylene (Teflon)FDA Link
05/2016

Therapy/Procedure

8Therapeutics
12/2017 - 10/2012
1Blood Component Removal (Apheresis)
06/2020
1Immunotherapy
01/2020
1Prostatectomy (Retropubic Prostatectomy)
11/2016